Cholesterol sulfate alters astrocyte metabolism and provides protection against oxidative stress

Abstract

Introduction Cholesterol sulfate (CS) is one of the most important known sterol sulfates in human plasma and present as a normal constituent in a variety of human tissues. In both the brain and periphery, CS serves as a substrate for the synthesis of sulfonated adrenal steroids such as pregnenolone sulfate and Dehydroepiandrosterone (DHEA) sulfate and as a constituent of many biological membranes including red blood cells where it functions as a stabilizing agent. It also acts as endogenous regulator of cholesterol synthesis. It is known that CS serves as a substrate for synthesizing other sterol sulfates in the brain. However, the role of CS in neurological insult and brain metabolism is unknown. Our goal in this study is to investigate the neuroprotective action of CS as well as its effect on brain energy metabolism. Materials and Methods Primary astrocytes were prepared from the cortex of postnatal day 0–2 C57BL/6 pups and seeded in Dulbecco's modified eagle medium (DMEM) with 10% FBS under normal glucose (5.5 mM). HT‐22 cells were maintained in high glucose (25 mM) DMEM supplemented with charcoal stripped FBS. The neuroprotective effect of CS and its role on cell metabolism were determined in primary astrocyte and HT‐22 cells using Calcien AM cell viability assay, flow cytometry, seahorse extracellular flux analysis, and metabolism assay kits. Results CS protects HT22 cells against glutamate toxicity and impact astrocyte metabolism by increasing ATP, and glycogen contents. Conclusion Our study demonstrated that CS have neuroprotective effect and modulate brain energy metabolism. Further studies are needed to determine the mechanisms underlying the neuroprotective action of CS and its action on brain energy metabolism. Support or Funding Information This work was partly supported by National Institutes of Health grants 1R21NS087209‐01A1 (SY) and R01NS088596 (SY). This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation

“…HT-22 cells were treated as described for the propidium iodide (PI) assay, and then the cells were incubated with calcein-AM for 30 min at 37 ℃. Photographs were captured with a fluorescence microscope (Prah et al 2019 ).…”

“…Subsequently, the membranes were washed with 1× TBST three times and incubated with secondary antibodies for 2 h at room temperature. Next, the membranes were scanned using the Odyssey ® CLx Imaging System (LI-COR Biosciences, United States) (Prah et al 2019 ; Li et al 2020b ). Finally, the gray values of the bands were compared using ImageJ software and GraphPad Prism 8.0.1 software.…”

Metabolic Regulation of Glial Phenotypes: Implications in Neuron–Glia Interactions and Neurological Disorders

“…Increased mitochondrial oxidative phosphorylation in primary astrocyte cultures following cholesterol sulfate treatment enhanced neuroprotective potential of astrocytes (Prah et al, 2019). The same study also found decreased phosphorylation of AMPK in astrocytes, which is a key regulator of glycolysis.…”

Sult2b1 deficiency exacerbates ischemic stroke by promoting pro-inflammatory macrophage polarization in mice

“…As early as in 1976, cholesterol sulfate was shown closely related to rat brain development 10 . Recently, cholesterol sulfate has been further shown had protective role against oxidative stress in brain astrocyte 11 . In addition, abnormal lipid expression is closely associated with various brain diseases 9 .…”